Nichole Reisdorph
Concepts (642)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 686 | 4.580 |
Why?
| | Mass Spectrometry | 23 | 2025 | 739 | 2.260 |
Why?
| | Metabolome | 12 | 2023 | 351 | 2.080 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 543 | 1.830 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 643 | 1.380 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.340 |
Why?
| | Proteomics | 12 | 2019 | 1109 | 1.290 |
Why?
| | Asthma | 12 | 2024 | 1890 | 1.230 |
Why?
| | Proteome | 8 | 2019 | 471 | 1.180 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 580 | 1.160 |
Why?
| | Lipids | 6 | 2022 | 681 | 1.110 |
Why?
| | Ozone | 6 | 2025 | 134 | 1.040 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 30 | 1.020 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.910 |
Why?
| | Tea | 1 | 2025 | 20 | 0.910 |
Why?
| | Research | 2 | 2018 | 451 | 0.880 |
Why?
| | Biomarkers | 25 | 2024 | 4111 | 0.850 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 441 | 0.840 |
Why?
| | Amino Acids | 4 | 2020 | 499 | 0.840 |
Why?
| | Lung | 14 | 2025 | 4065 | 0.820 |
Why?
| | Eicosanoids | 4 | 2022 | 62 | 0.760 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 109 | 0.740 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 184 | 0.730 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 1029 | 0.700 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.700 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.700 |
Why?
| | Animals | 60 | 2025 | 37151 | 0.690 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 29 | 0.690 |
Why?
| | Mice | 42 | 2025 | 17769 | 0.680 |
Why?
| | Pneumonia | 5 | 2025 | 638 | 0.670 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 14 | 0.660 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 86 | 0.650 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.640 |
Why?
| | Breath Tests | 2 | 2017 | 75 | 0.620 |
Why?
| | Food | 2 | 2020 | 168 | 0.620 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2121 | 0.610 |
Why?
| | Organic Chemicals | 1 | 2020 | 125 | 0.590 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.580 |
Why?
| | Peptide Mapping | 1 | 2018 | 64 | 0.580 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.580 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 38 | 0.570 |
Why?
| | Monocytes | 1 | 2021 | 563 | 0.560 |
Why?
| | Tyrosine | 1 | 2018 | 226 | 0.550 |
Why?
| | Isotope Labeling | 1 | 2018 | 80 | 0.550 |
Why?
| | Hypersensitivity | 4 | 2022 | 252 | 0.520 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 289 | 0.520 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 701 | 0.520 |
Why?
| | Skin | 3 | 2018 | 753 | 0.520 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 258 | 0.520 |
Why?
| | Humans | 75 | 2025 | 138102 | 0.510 |
Why?
| | Plasma | 2 | 2017 | 217 | 0.500 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 430 | 0.500 |
Why?
| | Smoking | 7 | 2020 | 1616 | 0.490 |
Why?
| | Macrophages | 2 | 2021 | 1544 | 0.480 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5769 | 0.480 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 134 | 0.470 |
Why?
| | Saliva | 1 | 2017 | 239 | 0.470 |
Why?
| | Dietary Supplements | 7 | 2025 | 565 | 0.460 |
Why?
| | Glycerophospholipids | 4 | 2022 | 34 | 0.460 |
Why?
| | Peptides | 4 | 2019 | 980 | 0.440 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.440 |
Why?
| | Computational Biology | 3 | 2020 | 649 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 596 | 0.440 |
Why?
| | Seafood | 2 | 2025 | 28 | 0.440 |
Why?
| | Leukotriene E4 | 3 | 2013 | 24 | 0.430 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 114 | 0.430 |
Why?
| | Mitochondria | 5 | 2023 | 951 | 0.420 |
Why?
| | Cell Differentiation | 2 | 2021 | 1999 | 0.410 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 180 | 0.400 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.400 |
Why?
| | Microbiota | 4 | 2022 | 761 | 0.380 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 91 | 0.380 |
Why?
| | Cholesterol | 3 | 2024 | 411 | 0.370 |
Why?
| | Endocannabinoids | 2 | 2022 | 64 | 0.370 |
Why?
| | Software | 4 | 2020 | 665 | 0.360 |
Why?
| | Sirtuin 3 | 3 | 2023 | 61 | 0.360 |
Why?
| | Vitamins | 2 | 2025 | 188 | 0.360 |
Why?
| | Autoantigens | 4 | 2019 | 423 | 0.360 |
Why?
| | Male | 45 | 2025 | 67984 | 0.360 |
Why?
| | Liver | 4 | 2020 | 1874 | 0.350 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3301 | 0.340 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 141 | 0.330 |
Why?
| | Sleep Deprivation | 2 | 2023 | 182 | 0.320 |
Why?
| | Transcriptome | 4 | 2022 | 969 | 0.320 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 208 | 0.300 |
Why?
| | Analgesia | 1 | 2010 | 96 | 0.300 |
Why?
| | Species Specificity | 2 | 2020 | 584 | 0.300 |
Why?
| | Kainic Acid | 2 | 2018 | 34 | 0.270 |
Why?
| | Workflow | 2 | 2020 | 164 | 0.270 |
Why?
| | Minerals | 2 | 2025 | 42 | 0.270 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 1946 | 0.270 |
Why?
| | Diet | 4 | 2024 | 1290 | 0.270 |
Why?
| | Urinalysis | 2 | 2020 | 77 | 0.260 |
Why?
| | Interleukin-13 | 3 | 2024 | 148 | 0.260 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 553 | 0.260 |
Why?
| | Female | 38 | 2025 | 73648 | 0.260 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 54 | 0.260 |
Why?
| | Middle Aged | 20 | 2025 | 33509 | 0.260 |
Why?
| | Inflammation Mediators | 2 | 2020 | 511 | 0.260 |
Why?
| | Obesity | 7 | 2024 | 3037 | 0.260 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4309 | 0.260 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 258 | 0.260 |
Why?
| | Blood Pressure | 4 | 2020 | 1802 | 0.250 |
Why?
| | Mucus | 2 | 2024 | 78 | 0.250 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 3 | 0.240 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 8 | 0.240 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 360 | 0.240 |
Why?
| | Diet, High-Fat | 3 | 2022 | 249 | 0.240 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 81 | 0.240 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 329 | 0.240 |
Why?
| | Food Analysis | 1 | 2025 | 26 | 0.240 |
Why?
| | Body Fluids | 2 | 2017 | 71 | 0.240 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 222 | 0.230 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 559 | 0.230 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.230 |
Why?
| | Metals, Heavy | 1 | 2025 | 31 | 0.230 |
Why?
| | Cell Line | 7 | 2024 | 2865 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.220 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.220 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.220 |
Why?
| | Ethanol | 2 | 2019 | 614 | 0.220 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1101 | 0.220 |
Why?
| | Membrane Microdomains | 1 | 2024 | 35 | 0.220 |
Why?
| | Sleep | 4 | 2023 | 793 | 0.220 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 101 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Lectins | 1 | 2024 | 46 | 0.210 |
Why?
| | Pilot Projects | 6 | 2022 | 1751 | 0.210 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 76 | 0.210 |
Why?
| | Feces | 2 | 2025 | 481 | 0.210 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 25 | 0.210 |
Why?
| | Mucin 5AC | 1 | 2024 | 70 | 0.210 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 47 | 0.210 |
Why?
| | Mice, Knockout | 10 | 2025 | 3014 | 0.210 |
Why?
| | Oxadiazoles | 1 | 2003 | 32 | 0.210 |
Why?
| | Eye Proteins | 1 | 2004 | 92 | 0.210 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 143 | 0.210 |
Why?
| | Proteins | 3 | 2017 | 1011 | 0.210 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 60 | 0.200 |
Why?
| | Isoxazoles | 1 | 2003 | 53 | 0.200 |
Why?
| | Rhinovirus | 1 | 2003 | 57 | 0.200 |
Why?
| | Capsid | 1 | 2003 | 90 | 0.200 |
Why?
| | Plant Extracts | 1 | 2025 | 209 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2022 | 64 | 0.190 |
Why?
| | Acylation | 2 | 2019 | 31 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2025 | 285 | 0.190 |
Why?
| | Prostaglandins | 2 | 2022 | 101 | 0.190 |
Why?
| | Myocardium | 3 | 2019 | 900 | 0.190 |
Why?
| | Drosophila Proteins | 1 | 2004 | 202 | 0.190 |
Why?
| | Cells, Cultured | 6 | 2021 | 4160 | 0.190 |
Why?
| | Oxidative Stress | 4 | 2021 | 1322 | 0.190 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.180 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 33 | 0.180 |
Why?
| | Hippocampus | 2 | 2018 | 903 | 0.180 |
Why?
| | Linear Models | 2 | 2018 | 861 | 0.180 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 60 | 0.180 |
Why?
| | Bacterial Toxins | 1 | 2022 | 104 | 0.180 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 93 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 68 | 0.180 |
Why?
| | Dinoprostone | 1 | 2022 | 192 | 0.180 |
Why?
| | Brain Chemistry | 1 | 2021 | 115 | 0.180 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 377 | 0.180 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 147 | 0.180 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 376 | 0.180 |
Why?
| | Calcifediol | 2 | 2022 | 33 | 0.180 |
Why?
| | Sepsis | 1 | 2007 | 602 | 0.180 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 24 | 0.180 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 23 | 0.170 |
Why?
| | Amidohydrolases | 1 | 2021 | 31 | 0.170 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 52 | 0.170 |
Why?
| | Neuroprotection | 1 | 2021 | 42 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 396 | 0.170 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 186 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2018 | 523 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 568 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.170 |
Why?
| | Oxylipins | 3 | 2025 | 41 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 60 | 0.160 |
Why?
| | Melatonin | 1 | 2021 | 155 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 85 | 0.160 |
Why?
| | Vital Capacity | 2 | 2018 | 302 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1760 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 135 | 0.160 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 134 | 0.160 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 116 | 0.160 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 11 | 0.160 |
Why?
| | Succinic Acid | 1 | 2019 | 39 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2020 | 550 | 0.160 |
Why?
| | Myofibrils | 1 | 2019 | 48 | 0.160 |
Why?
| | Umbilical Arteries | 1 | 2020 | 54 | 0.160 |
Why?
| | Lung Injury | 1 | 2022 | 218 | 0.160 |
Why?
| | Tubulin | 1 | 2020 | 145 | 0.160 |
Why?
| | Bariatric Surgery | 1 | 2022 | 218 | 0.150 |
Why?
| | Islets of Langerhans | 2 | 2019 | 793 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 32 | 0.150 |
Why?
| | Insulin | 3 | 2022 | 2405 | 0.150 |
Why?
| | Epithelium | 1 | 2020 | 316 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2020 | 124 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 74 | 0.150 |
Why?
| | Aging | 3 | 2023 | 1859 | 0.150 |
Why?
| | Liposomes | 1 | 2020 | 217 | 0.150 |
Why?
| | Rhinitis | 1 | 2020 | 157 | 0.150 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 20 | 0.150 |
Why?
| | Fluorenes | 1 | 2019 | 45 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 138 | 0.150 |
Why?
| | Aged | 11 | 2023 | 23995 | 0.150 |
Why?
| | Inhalation Exposure | 2 | 2021 | 106 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.150 |
Why?
| | Synapses | 1 | 2022 | 420 | 0.150 |
Why?
| | Trypsin | 1 | 2018 | 76 | 0.140 |
Why?
| | Spleen | 1 | 2020 | 521 | 0.140 |
Why?
| | C-Peptide | 2 | 2016 | 162 | 0.140 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 40 | 0.140 |
Why?
| | Adult | 15 | 2025 | 38063 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 77 | 0.140 |
Why?
| | Leukotrienes | 1 | 2018 | 36 | 0.140 |
Why?
| | Gene Expression | 4 | 2020 | 1487 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 203 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 257 | 0.140 |
Why?
| | Sinusitis | 1 | 2020 | 221 | 0.140 |
Why?
| | Bacteria | 1 | 2025 | 873 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 280 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 38 | 0.140 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 36 | 0.140 |
Why?
| | Limit of Detection | 1 | 2018 | 87 | 0.140 |
Why?
| | NAD | 1 | 2018 | 77 | 0.140 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.140 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 3 | 0.140 |
Why?
| | Niacinamide | 1 | 2018 | 82 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 132 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 324 | 0.130 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 243 | 0.130 |
Why?
| | Sample Size | 1 | 2017 | 124 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 55 | 0.130 |
Why?
| | Health | 1 | 2017 | 84 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2021 | 786 | 0.130 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 78 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 406 | 0.130 |
Why?
| | Autoimmunity | 2 | 2021 | 899 | 0.130 |
Why?
| | Artifacts | 1 | 2017 | 129 | 0.130 |
Why?
| | Proline | 1 | 2017 | 78 | 0.130 |
Why?
| | Disease | 1 | 2017 | 98 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 611 | 0.130 |
Why?
| | Immunophenotyping | 2 | 2018 | 324 | 0.130 |
Why?
| | Sphingolipids | 1 | 2017 | 77 | 0.130 |
Why?
| | Hyperglycemia | 1 | 2020 | 351 | 0.130 |
Why?
| | Actins | 1 | 2018 | 418 | 0.130 |
Why?
| | Immunity, Humoral | 1 | 2017 | 117 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 770 | 0.120 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 157 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 324 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 476 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 106 | 0.120 |
Why?
| | Acetylation | 3 | 2023 | 245 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.120 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 112 | 0.120 |
Why?
| | Signal Transduction | 4 | 2022 | 5068 | 0.120 |
Why?
| | Arginine | 1 | 2017 | 260 | 0.120 |
Why?
| | Cytokines | 4 | 2025 | 2079 | 0.120 |
Why?
| | Vascular Stiffness | 2 | 2018 | 497 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2555 | 0.120 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 185 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 31 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.120 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2159 | 0.120 |
Why?
| | Aorta | 2 | 2015 | 417 | 0.120 |
Why?
| | Brain | 2 | 2018 | 2725 | 0.110 |
Why?
| | Electrophysiology | 1 | 2015 | 217 | 0.110 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 320 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 354 | 0.110 |
Why?
| | Forensic Sciences | 1 | 2014 | 6 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 269 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 61 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 287 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 196 | 0.110 |
Why?
| | Carotid Arteries | 1 | 2015 | 209 | 0.110 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 91 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2022 | 1231 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 883 | 0.100 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 24 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 21 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 769 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3664 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 13 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 844 | 0.100 |
Why?
| | Education | 1 | 2013 | 112 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 98 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 437 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 42 | 0.100 |
Why?
| | Health Status | 1 | 2018 | 819 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2018 | 3569 | 0.100 |
Why?
| | Nasal Mucosa | 2 | 2024 | 105 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 189 | 0.100 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 195 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 816 | 0.090 |
Why?
| | Epilepsy | 1 | 2016 | 335 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1157 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 44 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 597 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 331 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 849 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1747 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1075 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2925 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1183 | 0.090 |
Why?
| | Fatty Acids | 3 | 2018 | 446 | 0.090 |
Why?
| | fas Receptor | 1 | 2011 | 96 | 0.090 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 343 | 0.090 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.090 |
Why?
| | Ovarian Follicle | 1 | 2011 | 72 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 338 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 714 | 0.090 |
Why?
| | Pregnancy | 5 | 2025 | 6789 | 0.090 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7638 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 266 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 67 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 305 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5564 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 56 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 116 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 93 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 15 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 26 | 0.080 |
Why?
| | Light | 2 | 2021 | 390 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 42 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2586 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 223 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1146 | 0.080 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 934 | 0.080 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 71 | 0.080 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 238 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 51 | 0.070 |
Why?
| | Binding Sites | 2 | 2020 | 1317 | 0.070 |
Why?
| | Glycoproteins | 1 | 2010 | 357 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 237 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 39 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 22 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 47 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 340 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 218 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 626 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2562 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 373 | 0.070 |
Why?
| | Inflammation | 3 | 2024 | 2847 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1033 | 0.070 |
Why?
| | Cognition | 1 | 2015 | 1173 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 373 | 0.070 |
Why?
| | Diet, Western | 2 | 2018 | 81 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 399 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2472 | 0.070 |
Why?
| | Child | 6 | 2024 | 21990 | 0.070 |
Why?
| | Biomedical Research | 1 | 2013 | 703 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2145 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 1003 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2019 | 348 | 0.060 |
Why?
| | Phenotype | 4 | 2018 | 3158 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 912 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2077 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 366 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2050 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 405 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 386 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1002 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 691 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 55 | 0.060 |
Why?
| | Iodine | 1 | 2025 | 27 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1260 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 61 | 0.060 |
Why?
| | Algal Proteins | 1 | 2004 | 6 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 69 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 73 | 0.050 |
Why?
| | Choline | 1 | 2025 | 131 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 391 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 55 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 37 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 279 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2232 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 7 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 635 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 168 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 621 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 157 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 204 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 9 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 13329 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 435 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 10 | 0.050 |
Why?
| | Introns | 1 | 2004 | 256 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 14 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 818 | 0.050 |
Why?
| | Exons | 1 | 2004 | 353 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 79 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1349 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 86 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2024 | 1100 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 46 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 392 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 3994 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 60 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 37 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3404 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2018 | 1922 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 132 | 0.050 |
Why?
| | HeLa Cells | 1 | 2003 | 635 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1154 | 0.050 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 155 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 141 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 987 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 635 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 18 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 21637 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 37 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 242 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 222 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 194 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 24 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 58 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 71 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1593 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 248 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 90 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2861 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 112 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 116 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 49 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 58 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2071 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 43 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 218 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 290 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 528 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 271 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 249 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 151 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 55 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5731 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 103 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 535 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1270 | 0.040 |
Why?
| | Water | 1 | 2003 | 468 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 44 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 117 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 115 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 98 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2374 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 124 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 335 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 208 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 91 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 648 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 398 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 228 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 481 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 401 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 552 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 853 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 171 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 146 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 331 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 203 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 243 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 179 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 150 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 250 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 847 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 176 | 0.040 |
Why?
| | Germinal Center | 1 | 2018 | 63 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 179 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 92 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.040 |
Why?
| | Models, Molecular | 1 | 2003 | 1598 | 0.040 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 18 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2018 | 28 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 384 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 285 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2029 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1473 | 0.030 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 163 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1265 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 152 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 154 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 288 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 323 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1495 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 498 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 421 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 506 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 33 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2799 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 354 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 18 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 938 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 791 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 801 | 0.030 |
Why?
| | Pyrrolidines | 1 | 2017 | 78 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 478 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 228 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 329 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 124 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 427 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 915 | 0.030 |
Why?
| | Family | 1 | 2021 | 673 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 416 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 826 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 111 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 422 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 568 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 21 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 310 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2422 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1239 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 289 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 332 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 263 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 6 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 65 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 25 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 30 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2838 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 752 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 198 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1397 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 92 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7603 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 274 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 807 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11142 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 100 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1791 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 826 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 407 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 212 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2827 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 376 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 22 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6845 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 56 | 0.030 |
Why?
| | Cyclopropanes | 1 | 2013 | 68 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 366 | 0.030 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.030 |
Why?
| | Androstadienes | 1 | 2013 | 77 | 0.030 |
Why?
| | Albuterol | 1 | 2013 | 74 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2730 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 80 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2022 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 320 | 0.020 |
Why?
| | Sulfides | 1 | 2013 | 82 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 424 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 487 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 154 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4553 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 348 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 214 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 514 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 923 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 481 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1804 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 373 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 43 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 452 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 588 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 296 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 158 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 320 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1012 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 854 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 505 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 895 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 86 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 491 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 57 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 86 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 9 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 588 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 30 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 155 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 59 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 788 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 224 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 35 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5556 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 306 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 54 | 0.020 |
Why?
| | Risk | 1 | 2011 | 906 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 117 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 39 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6140 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 104 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 180 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1381 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 406 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 93 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 174 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 124 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 246 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 944 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 210 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 432 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 600 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 873 | 0.020 |
Why?
| | Cell Membrane | 1 | 2009 | 713 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 442 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1711 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3285 | 0.020 |
Why?
| | Histones | 1 | 2010 | 636 | 0.010 |
Why?
| | United States | 1 | 2022 | 15028 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1237 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 467 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 901 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1755 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 23 | 0.010 |
Why?
| | Germination | 1 | 2003 | 6 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2693 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 110 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1983 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1431 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1419 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10433 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 5850 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|